These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28292361)

  • 1. Effectiveness of Per Rectal Misoprostol Versus Intramuscular Oxytocin for Prevention of Primary Postpartum Haemorrhage.
    Asmat R; Ashraf T; Asmat F; Asmat S; Asmat N
    J Coll Physicians Surg Pak; 2017 Jan; 27(1):13-17. PubMed ID: 28292361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal misoprostol versus intramuscular oxytocin for prevention of post partum hemorrhage.
    Shrestha A; Dongol A; Chawla CD; Adhikari RK
    Kathmandu Univ Med J (KUMJ); 2011; 9(33):8-12. PubMed ID: 22610801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study between rectally administered misoprostol as a prophylaxis versus conventional intramuscular oxytocin in post partum hemorrhage.
    Haque N; Bilkis L; Haque N; Bari MS; Haque S
    Mymensingh Med J; 2009 Jan; 18(1 Suppl):S40-44. PubMed ID: 19377430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum haemorrhage.
    Al-Sawaf A; El-Mazny A; Shohayeb A
    J Obstet Gynaecol; 2013 Apr; 33(3):277-9. PubMed ID: 23550857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.
    Chaudhuri P; Biswas J; Mandal A
    Int J Gynaecol Obstet; 2012 Feb; 116(2):138-42. PubMed ID: 22100204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of postpartum haemorrhage with sublingual misoprostol or oxytocin: a double-blind randomised controlled trial.
    Bellad MB; Tara D; Ganachari MS; Mallapur MD; Goudar SS; Kodkany BS; Sloan NL; Derman R
    BJOG; 2012 Jul; 119(8):975-82; discussion 982-6. PubMed ID: 22703421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trial.
    Diop A; Daff B; Sow M; Blum J; Diagne M; Sloan NL; Winikoff B
    Lancet Glob Health; 2016 Jan; 4(1):e37-44. PubMed ID: 26718808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery.
    Gerstenfeld TS; Wing DA
    Am J Obstet Gynecol; 2001 Oct; 185(4):878-82. PubMed ID: 11641670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study to compare the effectiveness of adjunctive rectal misoprostol or oxytocin titration in the prevention of primary post-partum haemorrhage in at risk patients.
    Muhammad R; Isah A; Agida T; Akaba G
    Afr Health Sci; 2019 Mar; 19(1):1517-1524. PubMed ID: 31148979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized comparison of rectal misoprostol with syntometrine on blood loss in the third stage of labour.
    Harriott J; Christie L; Wynter S; DaCosta V; Fletcher H; Reid M
    West Indian Med J; 2009 Jun; 58(3):201-6. PubMed ID: 20043525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum hemorrhage.
    Priya GP; Veena P; Chaturvedula L; Subitha L
    Arch Gynecol Obstet; 2015 Dec; 292(6):1231-7. PubMed ID: 25990482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage.
    Nasr A; Shahin AY; Elsamman AM; Zakherah MS; Shaaban OM
    Int J Gynaecol Obstet; 2009 Jun; 105(3):244-7. PubMed ID: 19249048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial.
    Winikoff B; Dabash R; Durocher J; Darwish E; Nguyen TN; León W; Raghavan S; Medhat I; Huynh TK; Barrera G; Blum J
    Lancet; 2010 Jan; 375(9710):210-6. PubMed ID: 20060161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage.
    Leduc D; Senikas V; Lalonde AB;
    J Obstet Gynaecol Can; 2009 Oct; 31(10):980-993. PubMed ID: 19941729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment for primary postpartum haemorrhage.
    Mousa HA; Alfirevic Z
    Cochrane Database Syst Rev; 2003; (1):CD003249. PubMed ID: 12535465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramuscular versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery: randomised controlled trial.
    Adnan N; Conlan-Trant R; McCormick C; Boland F; Murphy DJ
    BMJ; 2018 Sep; 362():k3546. PubMed ID: 30181338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind randomized controlled trial comparing misoprostol and oxytocin for management of the third stage of labor in a Nigerian hospital.
    Musa AO; Ijaiya MA; Saidu R; Aboyeji AP; Jimoh AA; Adesina KT; Abdul IF
    Int J Gynaecol Obstet; 2015 Jun; 129(3):227-30. PubMed ID: 25835642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral misoprostol versus oxytocin in the management of third stage of labour.
    Aziz S; Kazi S; Haq G; Soomro N
    J Pak Med Assoc; 2014 Apr; 64(4):428-32. PubMed ID: 24864638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of sublingual misoprostol to augment routine third-stage management among women at risk of postpartum hemorrhage.
    Chaudhuri P; Majumdar A
    Int J Gynaecol Obstet; 2016 Feb; 132(2):191-5. PubMed ID: 26613819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular versus intravenous prophylactic oxytocin for postpartum hemorrhage after vaginal delivery: a randomized controlled study.
    Dagdeviren H; Cengiz H; Heydarova U; Caypinar SS; Kanawati A; Guven E; Ekin M
    Arch Gynecol Obstet; 2016 Nov; 294(5):911-916. PubMed ID: 26980230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.